ZNF169
Zinc finger protein 169
Also known as: MGC51961, ZN169_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14929
- Gene
- ZNF169
- Ensembl
- ENSG00000175787
- Chromosome
- 9
- Canonical length
- 603 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nuclear speckles,Cytosol
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
603 residues, UniProt reviewed canonical sequence.
>Q14929|ZNF169
1 MSPGLLTTRK EALMAFRDVA VAFTQKEWKL LSSAQRTLYR EVMLENYSHL VSLGIAFSKP
61 KLIEQLEQGD EPWREENEHL LDLCPEPRTE FQPSFPHLVA FSSSQLLRQY ALSGHPTQIF
121 PSSSAGGDFQ LEAPRCSSEK GESGETEGPD SSLRKRPSRI SRTFFSPHQG DPVEWVEGNR
181 EGGTDLRLAQ RMSLGGSDTM LKGADTSESG AVIRGNYRLG LSKKSSLFSH QKHHVCPECG
241 RGFCQRSDLI KHQRTHTGEK PYLCPECGRR FSQKASLSIH QRKHSGEKPY VCRECGRHFR
301 YTSSLTNHKR IHSGERPFVC QECGRGFRQK IALLLHQRTH LEEKPFVCPE CGRGFCQKAS
361 LLQHQSSHTG ERPFLCLECG RSFRQQSLLL SHQVTHSGEK PYVCAECGHS FRQKVTLIRH
421 QRTHTGEKPY LCPQCGRGFS QKVTLIGHQR THTGEKPYLC PDCGRGFGQK VTLIRHQRTH
481 TGEKPYLCPK CGRAFGFKSL LTRHQRTHSE EELYVDRVCG QGLGQKSHLI SDQRTHSGEK
541 PCICDECGRG FGFKSALIRH QRTHSGEKPY VCRECGRGFS QKSHLHRHRR TKSGHQLLPQ
601 EVFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF169 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 5.9 nTPM
Expression across tissuesHPA
Tissue
- spleen: 5.9 nTPM
- cerebellum: 5.8 nTPM
- lymph node: 5.5 nTPM
- small intestine: 5.5 nTPM
- ovary: 5.3 nTPM
- cerebral cortex: 5.2 nTPM
Single-cell type
- goblet cells: 35 nCPM
- choroid plexus epithelial cells: 34 nCPM
- adrenal cortex cells: 34 nCPM
- microglia: 33 nCPM
- fibro-adipogenic progenitors: 29 nCPM
- distal convoluted tubule cells: 29 nCPM
Immune cell
- naive CD8 T-cell: 4.1 nTPM
- naive B-cell: 4 nTPM
- intermediate monocyte: 3.4 nTPM
- NK-cell: 3.2 nTPM
- eosinophil: 3.1 nTPM
- MAIT T-cell: 3.1 nTPM
Brain region
- white matter: 17 nTPM
- cerebral cortex: 15 nTPM
- pons: 14 nTPM
- cerebellum: 14 nTPM
- choroid plexus: 14 nTPM
- hippocampal formation: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.35
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.22
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF169 as an antibody target. Whether an autoantibody or antibody against ZNF169 could matter depends on whether native ZNF169 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF169 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF169 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...